DOCSLIB.ORG

ICD-10-CM Specialized Coding Workbook with Answers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-10-CM Specialized Coding Workbook with Answers DPH ICD-10 IMPLEMENTATION PROJECT ICD-10-CM SPECIALIZED CODING TRAINING WORKBOOK FOR LOCAL HEALTH DEPARTMENTS AND RURAL HEALTH CLINICS (WITH ANSWERS) WBS 2.5 Version 1.1 This Page Was Intentionally Left Blank 2 DPH ICD-10 Implementation Project WBS 2.5 – Training Materials ICD-10-CM Specialized Coding Training Workbook – With Answers Change History Version Number & Date Version Description Version Author Modifications made to coincide with Sarah Brooks revisions made in training materials wherein training was broken into Units. V1.0 – February 24, 2015 Instead of separate workbooks for each Specialized course, a single workbook is developed for the Specialized courses. V1.1 – February 26, 2015 Minor changes – final product Sarah Brooks 3 DPH ICD-10 Implementation Project WBS 2.5 – Training Materials ICD-10-CM Specialized Coding Training Workbook – With Answers Table of Contents 1. ICD-10-CM: THE CHAPTERS ........................................................................................................................... 9 2. ICD-10-CM: THE CHAPTER BLOCKS .......................................................................................................... 10 2.1 CHAPTER 1 - CERTAIN INFECTIOUS AND PARASITIC DISEASES (A00-B99) ...................................................... 10 2.2 CHAPTER 2 - NEOPLASMS (C00-D49) ............................................................................................................ 11 2.3 CHAPTER 3 - DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS AND CERTAIN DISORDERS INVOLVING THE IMMUNE MECHANISM (D50-D89) ..................................................................................................................... 12 2.4 CHAPTER 4 - ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES (E00-E89) .......................................... 12 2.5 CHAPTER 5 - MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS (F01-F99) .......................... 13 2.6 CHAPTER 6 - DISEASES OF THE NERVOUS SYSTEM (G00-G99) ..................................................................... 14 2.7 CHAPTER 7 – DISEASES OF THE EYE AND ADNEXA (H00-H59) ..................................................................... 14 2.8 CHAPTER 8 - DISEASES OF THE EAR AND MASTOID PROCESS (H60-H95) ........................................................ 15 2.9 CHAPTER 9 – DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) .................................................................. 15 2.10 CHAPTER 10 – DISEASES OF THE RESPIRATORY SYSTEM (J00-J99) ............................................................ 16 2.11 CHAPTER 11 – DISEASES OF THE DIGESTIVE SYSTEM (K00-K95) .............................................................. 16 2.12 CHAPTER 12 – DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE (L00-L99) ........................................ 17 2.13 CHAPTER 13 – DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE (M00-M99) ...... 17 2.14 CHAPTER 14 – DISEASES OF THE GENITOURINARY SYSTEM (N00-N99)..................................................... 18 2.15 CHAPTER 15 – PREGNANCY, CHILDBIRTH AND THE PUERPERIUM (O00-O9A) ........................................... 19 2.16 CHAPTER 16 – CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD (P00-P96) ....................... 19 2.17 CHAPTER 17 – CONGENITAL MALFORMATIONS, DEFORMATIONS AND CHROMOSOMAL ABNORMALITIES (Q00-Q99) .............................................................................................................................................................. 20 2.18 CHAPTER 18 – SYMPTOMS, SIGNS AND ABNORMAL CLINICAL AND LABORATORY FINDINGS, NOT ELSEWHERE CLASSIFIED (R00-R99) ........................................................................................................................ 21 2.19 CHAPTER 19 – INJURY, POISONING, AND CERTAIN OTHER CONSEQUENCES OF EXTERNAL CAUSES (S00- T88) 22 2.20 CHAPTER 20 – EXTERNAL CAUSES OF MORBIDITY (V01-Y99) ............................................................ 23 2.21 CHAPTER 21 – FACTORS INFLUENCING HEALTH STATUS AND CONTACT WITH HEALTH SERVICES (Z00-Z99) 24 3. ICD-10-CM: BEHAVIORAL HEALTH COURSE .......................................................................................... 25 3.1 BEHAVIORAL HEALTH COURSE UNIT 1 - REVIEW QUESTIONS ....................................................................... 25 3.2 BEHAVIORAL HEALTH COURSE UNIT 1 – CODING EXERCISE ......................................................................... 26 3.3 BEHAVIORAL HEALTH COURSE UNIT 2 - REVIEW QUESTIONS ....................................................................... 27 3.4 BEHAVIORAL HEALTH COURSE UNIT 2 – CODING EXERCISE ......................................................................... 28 4. ICD-10-CM: CHILD HEALTH AND HEALTH CHECK COURSE ............................................................... 29 4.1 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 1 - REVIEW QUESTIONS ................................................ 29 4 DPH ICD-10 Implementation Project WBS 2.5 – Training Materials ICD-10-CM Specialized Coding Training Workbook – With Answers 4.2 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 1 – CODING EXERCISES ................................................ 30 4.3 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 2 - REVIEW QUESTIONS ................................................ 31 4.4 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 2 – CODING EXERCISE .................................................. 32 4.5 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 3 - REVIEW QUESTIONS ................................................ 33 4.6 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 3 - CODING EXERCISES ................................................. 34 4.7 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 4 - REVIEW QUESTIONS ................................................ 35 4.8 CHILD HEALTH AND HEALTH CHECK COURSE UNIT 4 - CODING EXERCISES ................................................. 36 4.9 CHILD HEALTH AND HEALTH CHECK COURSE UNITS 1 - 4 CODING EXERCISES ............................................ 37 5. ICD-10-CM: FAMILY PLANNING COURSE ................................................................................................. 39 5.1 FAMILY PLANNING COURSE UNIT 1 - REVIEW QUESTIONS ............................................................................ 39 5.2 FAMILY PLANNING COURSE UNIT 1 – CODING EXERCISE .............................................................................. 40 5.3 FAMILY PLANNING COURSE UNIT 2 - REVIEW QUESTIONS ............................................................................ 41 5.4 FAMILY PLANNING COURSE UNIT 2 – CODING EXERCISE .............................................................................. 42 6. ICD-10-CM: MATERNAL HEALTH COURSE .............................................................................................. 44 6.1 MATERNAL HEALTH COURSE UNIT 1 - REVIEW QUESTIONS .......................................................................... 44 6.2 MATERNAL HEALTH COURSE UNIT 1 – CODING EXERCISES .......................................................................... 45 6.3 MATERNAL HEALTH COURSE UNIT 2 - REVIEW QUESTIONS .......................................................................... 46 6.4 MATERNAL HEALTH COURSE UNIT 2 – CODING EXERCISE ............................................................................ 47 7. ICD-10-CM: PRIMARY CARE AND CHRONIC DISEASE COURSE .......................................................... 49 7.1 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 1 - REVIEW QUESTIONS ............................................ 49 7.2 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 1 – CODING EXERCISES ............................................ 50 7.3 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 2 - REVIEW QUESTIONS ............................................ 51 7.4 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 2 – CODING EXERCISE .............................................. 52 7.5 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 3 - REVIEW QUESTIONS ............................................ 53 7.6 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 3 - CODING EXERCISES ............................................. 53 7.7 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 4 - REVIEW QUESTIONS ............................................ 55 7.8 PRIMARY CARE AND CHRONIC DISEASE COURSE UNIT 4 - CODING EXERCISES ............................................. 56 8. ICD-10-CM: STD, HIV, COMMUNICABLE DISEASE COURSE ................................................................. 60 8.1 STD, HIV, COMMUNICABLE DISEASE COURSE UNIT 1 - REVIEW QUESTIONS ............................................... 60 8.2 STD, HIV, COMMUNICABLE DISEASE COURSE UNIT 1 – CODING EXERCISE ................................................. 61 8.3 STD, HIV, COMMUNICABLE DISEASE COURSE UNIT 2 - REVIEW QUESTIONS ............................................... 62 8.4 STD, HIV, COMMUNICABLE DISEASE COURSE UNIT 2 – CODING EXERCISES ............................................... 63 9. ICD-10-CM: WOMEN’S HEALTH AND BCCCP COURSE .......................................................................... 65 9.1 WOMEN’S HEALTH AND BCCCP COURSE UNIT 1 - REVIEW QUESTIONS ....................................................... 65 9.2 WOMEN’S HEALTH AND BCCCP COURSE UNIT 1 – CODING EXERCISES ....................................................... 66 9.3 WOMEN’S HEALTH AND BCCCP COURSE UNIT 2 - REVIEW QUESTIONS ....................................................... 67 5 DPH ICD-10 Implementation Project WBS 2.5 – Training Materials
Load more

Recommended publications
  • Future of Breast Elastography
    Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
    [Show full text]
  • The Healthcare System in Saudi Arabia and Its Challenges: the Case of Diabetes Care Pathway
    Journal of Health Informatics in Developing Countries www.jhidc.org Vol. 10 No. 1, 2016 Submitted: October 6, 2015 Accepted: January 17, 2016 The Healthcare System in Saudi Arabia and its Challenges: The Case of Diabetes Care Pathway Sarah Hamad ALKADI King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia Abstract. The advances of Information Technology (IT) play an important role globally in improving quality and capacity of healthcare sector. IT helps the health professions in managing resources and increasing productivity effectively. Although the conversion from paper to electronic patient records (EPR) conveys many benefits for both caregivers and caretakers, but also has brought many challenges in different aspects. Hospitals have implemented EPR to different degrees. They have used a set of standards in order to insure that data is accurately and consistently processed. Even though, the standardization of how data are captured, exchanged and used includes a set of complications that should be discovered to provide better health data quality for patients with multiple healthcare providers. Therefore, through an analysis of the EPR systems utilization in Saudi Arabia and the diabetes care pathway, three factors have been determined. These factors affect the workflow of the implementation and utilization of health information system (HIS) in terms of capturing, sharing and using its data efficiently. Keywords. HIS, EPR, information sharing, social factors, standards, health information management, diabetes care pathway, health informatics, data capturing, data sharing, Saudi Arabia. 1. Introduction The technology investment in health sector has importance in the management of healthcare services delivery in the developing countries. It is necessary to enhance the utilization as well as the implementation of HIS through standardizing the medical data in order to have a better data quality and more reliable system.
    [Show full text]
  • Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
    Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
    [Show full text]
  • Breast Ultrasound Accreditation Program Requirements
    Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Information for Referrers: Chronic Urticaria
    Fact Sheet Information for Referrers: Chronic Urticaria Chronic urticaria (CU) is defined by the presence of urticaria (wheals, hives) on most days of the week, for longer than six weeks. Angioedema occurs in about 40 percent of patients with CU and usually affects the lips, cheeks, periorbital areas, extremities, and genitals (seldom the tongue, throat or airway). In many cases, the underlying cause is autoimmunity (autoantibodies to the mast cell IgE receptor). Food allergy is almost never the cause. Chronic urticaria can cause marked distress because it is physically uncomfortable, waxes and wanes unpredictably, and may interfere with work/school and sleep. When to refer CU patients: > Where CU is not controlled by antihistamines or has persisted for more than 6 months. > Where there is concern patients are undertaking inappropriate dietary restrictions. > Where angioedema has involved the oropharyngeal or laryngeal areas. > Any features that might suggest an autoimmune or inflammatory disorder. > Where there are features to suggest urticarial vasculitis (lesions lasting >24 hours, burning rather than itching, residual bruising). > Where prednisolone has been needed repeatedly to control symptoms. Reassurance Patients with CU are often frustrated, and reassurance is an important component of successful management. There are three important concepts to relay to patients: > CU is usually transient, and 50 percent of patients undergo remission within one year. > While acute urticaria may be a manifestation of allergy and may be associated with anaphylaxis, chronic urticaria is a different disorder that is usually not allergic in origin and is not dangerous. > The symptoms of CU can be successfully managed in the majority of patients.
    [Show full text]
  • Screening Automated Whole Breast Ultrasound
    Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Stanford now offers screening automated whole breast ultrasound (SAWBU) at our Stanford Medicine Cancer Center Palo Alto location. This is an optional test that can be used as a supplement to screening mammography in women with mammographically dense breasts. It can find cancers that cannot be seen on mammograms due to overlap with dense breast tissue. Stanford uses automated whole breast technique, a new method developed for accuracy and efficiency. Who is a candidate for SAWBU What will happen during the How is SAWBU exam is examination? SAWBU examination? different? This is an optional test to supplement You will lie on your back, and gel will Screening automated screening mammography in women be applied to your breast. whole breast ultrasound who: uses sound waves (no radi- A large ultrasound handpiece will be • Undergo routine screening with ation) to create 3D pictures placed on the breast, and the system mammography. of the breast tissue, using will automatically take a “sweep” • Have no current signs or a new automated method that obtains ultrasound images of symptoms of breast cancer. developed for accuracy and the tissue from top to bottom. The • Have mammographically dense efficiency. handpiece will be repositioned to take (heterogeneously or extremely other “sweeps” to include all of the It can find cancers that dense) breasts. breast tissue. cannot be seen on mam- • Are not at “high risk" undergoing mograms alone due to supplemental screening with An exam of both breasts takes less overlap with dense breast breast MRI. Screening ultra- than 20 minutes to obtain.
    [Show full text]
  • Evaluation of the Quantitative Accuracy of a Commercially-Available Positron Emission Mammography Scanner
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER Adam Springer Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Diagnosis Commons, Equipment and Supplies Commons, and the Other Medical Sciences Commons Recommended Citation Springer, Adam, "EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 64. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/64 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY- AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER
    [Show full text]
  • The Health and Welfare of Australia's Aboriginal and Torres Strait Islander People: an Overview (Full Publication; 5 May
    The health and welfare of Australia’s Aboriginal and Torres Strait Islander people an overview 2011 The Australian Institute of Health and Welfare is Australia’s national health and welfare statistics and information agency. The Institute’s mission is better information and statistics for better health and wellbeing. © Australian Institute of Health and Welfare 2011 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without prior written permission from the Australian Institute of Health and Welfare. Requests and enquiries concerning reproduction and rights should be directed to the Head of the Communications, Media and Marketing Unit, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601. A complete list of the Institute’s publications is available from the Institute’s website <www.aihw.gov.au>. ISBN 978 1 74249 148 6 Suggested citation Australian Institute of Health and Welfare 2011. The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. Cat. no. IHW 42. Canberra: AIHW. Australian Institute of Health and Welfare Board Chair Hon. Peter Collins, AM, QC Director David Kalisch Any enquiries about or comments on this publication should be directed to: Communication, Media and Marketing Unit Australian Institute of Health and Welfare GPO Box 570 Canberra ACT 2601 Phone: (02) 6244 1032 Email: [email protected] Published by the Australian Institute of Health and Welfare Printed by Paragon Printers Australasia Please note that there is the potential for minor revisions of data in this report. Please check the online version at <www.aihw.gov.au> for any amendments.
    [Show full text]
  • Consensus Recommendations for National and State Poisoning Surveillance
    Consensus Recommendations for National and State Poisoning Surveillance REPORT FROM THE INJURY SURVEILLANCE WORKGROUP (ISW7) April 2012 Table of Contents FOREWORD 3 EXECUTIVE SUMMARY 4 Key products of the ISW7 include: 4 INTRODUCTION 6 Public Health Burden of Poisoning 7 CONCEPTUAL DEFINITIONS OF POISONING AND DRUG 9 Poisoning 9 Drug 10 OPERATIONAL DEFINITIONS OF POISONING AND DRUG POISONING 12 Description of the Poisoning Matrix for ICD-9-CM Coded Morbidity Data 12 Description of Poisoning Matrix for ICD-10 Coded Mortality Data 15 Operational Definitions for Other Major Data Sources 18 INVENTORY OF POISONING DATA SOURCES 20 GENERAL CONSIDERATIONS AND RECOMMENDATIONS FOR IMPROVING POISONING SURVEILLANCE 21 General considerations 21 Recommendations for proposed drug poisoning indicators for surveillance for state and local jurisdictions 21 Considerations for further sub-categorizations of indicators 24 RECOMMENDATIONS TO IMPROVE SURVEILLANCE AT THE STATE OR LOCAL LEVEL 25 Mortality surveillance 25 Morbidity surveillance 25 RECOMMENDATIONS TO IMPROVE SURVEILLANCE AT THE NATIONAL LEVEL 27 REFERENCES 29 APPENDICES 31 Appendix A: Detailed Description of Data Sources 32 Appendix B1: Poisoning Matrix for ICD-10 Coded Mortality Data 94 Appendix B2: SAS Programs for Poisoning Matrix for ICD-10 Coded Mortality Data 99 Appendix C1: Poisoning Matrix for ICD-9-CM Coded Morbidity Data 101 Appendix C2: SAS Programs for Poisoning Matrix for ICD-9-CM Coded Morbidity Data 106 Appendix D: List of ISW7 Workgroup Members 107 Consensus Recommendations for National and State Poisoning Surveillance 1 Methodology for this report: The Injury Surveillance Workgroup 7 worked from July 2009 through April 2012 using monthly conference calls, and more frequently through small subgroup calls, to develop this report.
    [Show full text]
  • Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound)
    Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound) Background interpreting physician, referring physician/Health Care Provider (HCP), and patient.6 Specifically, the MQSA encourages education More than one-half of women younger than 50 years old and and outreach to patients from medical/scientific organizations, approximately one-third of women 50 years and older have industry, and interpreting physicians. In addition, outreach to dense breasts in the US.1 Higher breast density is associated referring physicians is encouraged from professional organizations with decreased mammographic sensitivity and specificity and and Continuing Medical Education (CME) providers.6 increased breast cancer risk.2 Due to the shortcomings of mammography in this population of women, an individualized Despite widely available options for additional screening and multimodal screening approach is recommended to improve the legislation mandating density inform, uptake and adoption of early detection of breast cancer. No clinical guidelines explicitly supplemental screening has lagged. In addition to knowledge recommend use of supplemental breast cancer screening on gaps, one study identified reimbursement uncertainties (e.g. women with dense breasts,3 but as of March 2018, 33 states have billing, coding and coverage) as a key factor for slow uptake. In enacted legislation requiring that breast density, in addition to 2015, the CPT® codebook was updated to include two new codes mammography results, be reported to women undergoing such for breast ultrasound, CPT 76641 and 76642, for complete and procedures; additional states have introduced or are currently limited exams, respectively.7 These codes replaced CPT 76645. working on legislation.4 Most states require specific density The new and old codes alike do not differentiate the technology inform language distinguishing dense (i.e., BI-RADS® C and D) used to perform an exam (handheld vs.
    [Show full text]
  • What Is Medical Coding? What Is Medical Coding? Medical Coding Professionals Provide a Key Step in the Medical Billing Process
    Training Certification Continuing Education ICD-10 Jobs Networking Resources Store Log In / Join Certification Overview Medical Coding Certification Medical Billing Certification Medical Auditing Certification Medical Compliance Certification Practice Manager Certification Locate Exam Prepare for Exam Exam Tips Credential Verification FAQ Home > Medical Coding > What is Medical Coding? What is Medical Coding? Medical coding professionals provide a key step in the medical billing process. Every time a patient receives professional health care in a physician’s office, hospital outpatient facility or ambulatory surgical center (ASC), the provider must document the services provided. The medical coder will abstract the information from the documentation, assign the appropriate codes, and create a claim to be paid, whether by a commercial payer, the patient, or CMS. Prepare for certification and a career in medical coding Validate your knowledge, skills, and expertise with medical coding certification Is Medical Coding the same as Medical Billing? No. While the medical coder and medical biller may be the same person or may work closely together to make sure all invoices are paid properly, the medical coder is primarily responsible for abstracting and assigning the appropriate coding on the claims. In order to accomplish this, the coder checks a variety of sources within the patient’s medical record, (i.e. the transcription of the doctor’s notes, ordered laboratory tests, requested imaging studies and other sources) to verify the work that was done. Then the coder must assign CPT® codes, ICD-9 codes and HCPCS codes to both report the procedures that were performed and to provide the medical biller with the information necessary to process a claim for reimbursement by the appropriate insurance agency.
    [Show full text]